TrialBeacon
USClinicalTrials.govClinical trialNot applicableActive, not recruiting

Adaptive Symptom Self-Management Immunotherapy Study

Official record

Identifier
NCT05715255
Recruiting locations

country

United States
Interventions studied
Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)Active control comparator
Lead sponsor
University of Arizona
Target enrolment
400 participants
Study type
INTERVENTIONAL
Phase
Not applicable
Status
Active, not recruiting
First posted
Feb 6, 2023
Last updated on the registry
Jul 31, 2026
Age
18 Years
Sex
ALL
Study contact
No public contact is listed on the official record.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Age 18 or older
* Within 12 weeks after starting ICI treatment for cancer
* Cognitively oriented to person, place and time (determined by recruiter)
* Able to speak and understand English or Spanish
* Access to a telephone
* Severity score of 1 (mild) or higher on at least 1 of the 3 indicators of psychological distress from the PRO-CTCAE (i.e., the three items of anxious, discouraged, sad) library

Exclusion Criteria:

* Currently receiving regular behavioral counseling

This site does not provide medical advice

TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.